Get Started

BYSI

NASD BeyondSpring Inc.
Nov 3, 2026 · 4:49 AM ET LAST TRADE Market Closed

$0.7700 ↓ -0.0359 (-4.45%) Trading Down from the previous close of $0.8059

YTD change
-52.76%
vs 20-day SMA
+36.01%
vs 200-day SMA
-39.28%

Price ranges

Previous day
$0.6245 $0.8970
open $0.6294 close $0.8059
+$0.1765 (+28.04%)
Today
$0.0000 $0.0000
$0.7700
Past week
$0.4600 $0.8970
from $0.4600 now $0.7700
+$0.3100 (+67.39%)
Past month
$0.4215 $0.8970
from $0.7860 now $0.7700
-$0.0160 (-2.04%)
This year
$0.4215 $1.9200
from $1.6300 now $0.7700
-$0.8600 (-52.76%)

Price & Performance

-0.70 (-46.63%) / 6M

$0.3160$0.8724$1.43$1.99May 4Aug 4Nov 2

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral
  • The stock is 98.4% away from all-time highs of $48.4900
  • BYSI is down 53% since the beginning of the year
  • BYSI is down 63% over the past 12 months
  • BYSI is down 2% over the past 1 month
  • 7% of all BYSI investors are betting against BYSI

BYSI reads neutral: price sits above one of the two key moving averages, the 12-month move is -61.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.0206
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $19.7M
Beta 1.38

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$6.5M
Debt$171.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $31.7M

BeyondSpring, Inc. engages in the development and commercialization of immuno-oncology cancer therapies. It operates through the Plinabulin Pipeline and TPD Platform segments. The Plinabulin Pipeline segment focuses on the development of cancer therapies. The TPD Platform segment engages in the development of therapeutic agents and discover chemical entities. The company was founded by Lan Huang and Lin Qing Jia in 2010 and is headquartered in Florham Park, NJ.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $465.45 -0.12%
MRNA Moderna, Inc. $220.83 -0.40%
RVMD Revolution Medicines, Inc. $188.17 -1.64%
ROIV Roivant Sciences Ltd. $35.89 -2.76%
BNTX BioNTech SE Sponsored ADR $87.53 -0.73%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.